Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Prenen H"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 179
Tytuł:
155P A phase I study exploring the safety and tolerability of the small-molecule PD-L1 inhibitor INCB099280 in select advanced solid tumors
Autorzy:
Prenen, H.
Lesimple, T.
Robert, M.
Machiels, J-P.
Delafontaine, B.R.
Tomasini, P.
Meniawy, T.
Kotecki, N.
Van Cutsem, E.
Piha-Paul, S.A.
Schweizer, M.T.
Gadgeel, S.
Kondo, S.
Ouali, K.
Kuboki, Y.
Daniel, J.
Ebiana, V.
Howe, J.
Spitz, S.
Italiano, A.
Pokaż więcej
Źródło:
In Immuno-Oncology and Technology December 2023 20 Supplement
Czasopismo naukowe
Szczegóły
Tytuł:
Comprehensive Genomic Profiling and Therapeutic Implications for Patients with Advanced Cancers: The Experience of an Academic Hospital.
Autorzy:
Teuwen LA; Department of Oncology, Antwerp University Hospital, Drie Eikenstraat 655, 2650 Edegem, Belgium.
Roets E; Department of Oncology, Antwerp University Hospital, Drie Eikenstraat 655, 2650 Edegem, Belgium.
D'Hoore P; Department of Oncology, Antwerp University Hospital, Drie Eikenstraat 655, 2650 Edegem, Belgium.
Pauwels P; Department of Pathology, Antwerp University Hospital, Drie Eikenstraat 655, 2650 Edegem, Belgium.; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.
Prenen H; Department of Oncology, Antwerp University Hospital, Drie Eikenstraat 655, 2650 Edegem, Belgium.; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.
Pokaż więcej
Źródło:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2023 May 03; Vol. 13 (9). Date of Electronic Publication: 2023 May 03.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter Study.
Autorzy:
Delombaerde D; Integrated Cancer Center Ghent, Department of Medical Oncology, AZ Maria Middelares, 9000 Ghent, Belgium.; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610 Wilrijk, Belgium.
De Sutter J; Department of Cardiology, AZ Maria Middelares, 9000 Ghent, Belgium.; Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.
Croes L; Integrated Cancer Center Ghent, Department of Medical Oncology, AZ Maria Middelares, 9000 Ghent, Belgium.; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610 Wilrijk, Belgium.
Vervloet D; Department of Cardiology, AZ Maria Middelares, 9000 Ghent, Belgium.
Moerman V; Department of Cardiology, AZ Maria Middelares, 9000 Ghent, Belgium.
Van de Veire N; Department of Cardiology, AZ Maria Middelares, 9000 Ghent, Belgium.; Department of Cardiology, Free University Brussels, 1000 Brussels, Belgium.
Willems AM; Department of Cardiology, AZ Maria Middelares, 9000 Ghent, Belgium.
Wouters K; Antwerp University Hospital, Clinical Trial Center (CTC), CRC Antwerp, 2650 Edegem, Belgium.
Peeters M; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610 Wilrijk, Belgium.; Multidisciplinary Oncologic Center Antwerp (MOCA), Antwerp University Hospital, 2650 Edegem, Belgium.
Prenen H; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610 Wilrijk, Belgium.; Multidisciplinary Oncologic Center Antwerp (MOCA), Antwerp University Hospital, 2650 Edegem, Belgium.
Vulsteke C; Integrated Cancer Center Ghent, Department of Medical Oncology, AZ Maria Middelares, 9000 Ghent, Belgium.; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610 Wilrijk, Belgium.
Pokaż więcej
Źródło:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2023 Apr 20; Vol. 16 (4). Date of Electronic Publication: 2023 Apr 20.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cellular senescence in cancer: clinical detection and prognostic implications.
Autorzy:
Domen A; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610, Wilrijk (Antwerp), Belgium. .; Department of Oncology, Antwerp University Hospital (UZA), 2650, Edegem (Antwerp), Belgium. .
Deben C; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610, Wilrijk (Antwerp), Belgium.
Verswyvel J; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610, Wilrijk (Antwerp), Belgium.
Flieswasser T; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610, Wilrijk (Antwerp), Belgium.
Prenen H; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610, Wilrijk (Antwerp), Belgium.; Department of Oncology, Antwerp University Hospital (UZA), 2650, Edegem (Antwerp), Belgium.
Peeters M; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610, Wilrijk (Antwerp), Belgium.; Department of Oncology, Antwerp University Hospital (UZA), 2650, Edegem (Antwerp), Belgium.
Lardon F; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610, Wilrijk (Antwerp), Belgium.
Wouters A; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610, Wilrijk (Antwerp), Belgium.
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2022 Dec 27; Vol. 41 (1), pp. 360. Date of Electronic Publication: 2022 Dec 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Cellular Senescence*/genetics
Neoplasms*/pathology
Humans ; Prognosis ; Cell Cycle Checkpoints/genetics ; Cell Transformation, Neoplastic/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
341 (PB121) - MCLA-129, a human anti-EGFR and anti-c-MET bispecific antibody, in patients with advanced NSCLC and other solid tumors: an ongoing phase 1/2 study.
Autorzy:
Ou, S.H. (AUTHOR)
Moreno Garcia, V. (AUTHOR)
Gil Bazo, I. (AUTHOR)
Prenen, H. (AUTHOR)
Moreno, I. (AUTHOR)
Johnson, M. (AUTHOR)
Castañón Álvarez, E. (AUTHOR)
Nagasaka, M. (AUTHOR)
Adeyemi, S. (AUTHOR)
Barasa, B. (AUTHOR)
Bol, K. (AUTHOR)
Doze, P. (AUTHOR)
Engbers, A. (AUTHOR)
Joe, A.K. (AUTHOR)
Stalbovskaya, V. (AUTHOR)
Laus, G. (AUTHOR)
Call, J. (AUTHOR)
Pokaż więcej
Źródło:
European Journal of Cancer. 2022 Supplement 1, Vol. 174, pS122-S122. 1p.
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 179

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies